What is this medication?
Monoclonal Antibody; Anti-Asthmatic
Indicated for treatment of asthma; chronic idiopathic urticaria.
“ALERT: US Boxed Warning
Anaphylaxis, presenting as bronchospasm, hypotension, syncope, urticaria, and/or angioedema of the throat or tongue, has been reported to occur after administration of omalizumab. Anaphylaxis has occurred as early as after the first dose of omalizumab but also has occurred beyond 1 year after beginning regularly administered treatment. Because of the risk of anaphylaxis, observe patients closely for an appropriate period of time after omalizumab administration. Health care providers administering omalizumab should be prepared to manage anaphylaxis that can be life-threatening. Inform patients of the signs and symptoms of anaphylaxis and instruct them to seek immediate medical care if symptoms occur.”
How does this medication work?
Omalizumab, Xolair is a recombinant DNA IgG monoclonal antibody which blocks the high-affinity IgE receptor on mast cells and basophils. Decreasing bound IgE, the activation and release of allergic response mediators is reduced. Serum free IgE levels and the number of high-affinity IgE receptors are decreased. Long-term treatment in patients with allergic asthma showed a decrease in asthma exacerbations and corticosteroid usage. The mechanism by which these effects of omalizumab result in an improvement of chronic idiopathic urticaria symptoms is unknown.
How should I take this medication?
Dose and frequency based on body weight and pre-treatment total IgE serum levels.
How to Take: Administer via subcutaneous injection. No more than 150mg should be injected in one injection site. Doses over 150mg should be divided into multiple injections of no more than 150mg per injection. Each injection site should be separated by ≥1 inch. Injections may take 5 to 10 seconds to administer (solution is slightly viscous). Administer only under direct medical supervision and observe patient for 2 hours after the first 3 injections and 30 minutes after subsequent injections or in accordance with individual institution policies and procedures. Store under refrigeration at 2°C to 8°C (36°F to 46°F) in the original carton and protect from direct sunlight.
You Need to Avoid: Do not inject into moles, scars, bruises, tender areas, or broken skin. Do not freeze product.
What should I watch for while using this medication?
Before starting Omalizumab, Xolair make sure your physician is aware of any allergies or medications you currently take, if you are high risk for parasitic helminth infections, are pregnant, or breastfeeding. Omalizumab, Xolair use has been associated with rare but serious adverse events such as cerebrovascular effects, eosinophilia, vasculitis, fever, arthralgia, rash, hypersensitivity reactions, and malignant neoplasms.
What if I miss a dose?
For the best possible benefit, it is important to receive each scheduled dose of this medication as directed. If you miss a dose, contact your doctor or pharmacist immediately to establish a new dosing schedule.
How should I store this medication?
Keep out of the reach of children at all times. Store in the refrigerator, between 36°F and 46°F. DO NOT FREEZE. (Do not use if the prefilled syringe has been frozen.) Store it in the original packaging to protect it from light.
What are the possible side effects of using this medication?
Headache, injection site reaction, pain, arthralgia, nasopharyngitis, sinusitis
Note this is not a complete list of side effects, only common ones.
- Choosing a selection results in a full page refresh.
- Press the space key then arrow keys to make a selection.